scispace - formally typeset
K

Katharina Wimmer

Researcher at Innsbruck Medical University

Publications -  78
Citations -  3523

Katharina Wimmer is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Gene & Lynch syndrome. The author has an hindex of 30, co-authored 69 publications receiving 2987 citations. Previous affiliations of Katharina Wimmer include Medical University of Vienna & University of Vienna.

Papers
More filters
Journal ArticleDOI

Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation.

Magdalena Koczkowska, +69 more
- 01 Apr 2019 - 
TL;DR: It is demonstrated that individuals with the NF1 p.Met992del pathogenic variant have a mild NF1 phenotype lacking clinically suspected plexiform, cutaneous, or subcutaneous neurofibromas, however, learning difficulties are clearly part of the phenotypic presentation in these individuals and will require specialized care.
Journal ArticleDOI

GAB2 is a novel target of 11q amplification in AML/MDS.

TL;DR: The adaptor molecule GAB2 that has already been shown to enhance oncogenic signaling in other neoplasias appears as a novel target of 11q amplification in AML/MDS.
Journal ArticleDOI

A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency

TL;DR: In a 14-year-old boy with polyposis and rectosigmoid carcinoma, a novel POLE germline mutation is identified, previously found as recurrent somatic mutation in ‘ultramutated’ sporadic cancers, indicating that POLE mutation p.(Val411Leu) may confer a more severe phenotype than previously reported POLE and POLD1 germline mutations.
Journal ArticleDOI

Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.

TL;DR: Three children who had in addition to CMMR‐D‐associated malignancies multiple pilomatricomas are reported, indicating that CTNNB1 is a target for mutations when mismatch repair is impaired due to biallelic PMS2 mutations.